blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1617218

EP1617218 - METHOD OF SCREENING DRUG WITH THE USE OF 67 kDa LAMININ RECEPTOR [Right-click to bookmark this link]
Former [2006/03]METHOD OF SCREENING DRUG WITH THE USE OF 67 kDa LAMININ RECEPTOR AND DRUG OBTAINED THEREBY
[2010/39]
StatusNo opposition filed within time limit
Status updated on  30.12.2011
Database last updated on 24.04.2024
Most recent event   Tooltip04.10.2013Lapse of the patent in a contracting state
New state(s): HU		published on 06.11.2013  [2013/45]
Applicant(s)For all designated states
Kyushu TLO Company, Limited
10-1, Hakozaki 6-chome, Higashi-ku
Fukuoka-shi, Fukuoka 812-8581 / JP
[2006/03]
Inventor(s)01 / TACHIBANA, Hirofumi
7-8, Kashiihama 4-chome, Higashi-ku
Fukuoka-shi, Fukuoka 8130016 / JP
 [2006/03]
Representative(s)Zimmermann, Gerd Heinrich, et al
Zimmermann & Partner Patentanwälte mbB
Postfach 330 920
80069 München / DE
[N/P]
Former [2006/03]Zimmermann, Gerd Heinrich, et al
Zimmermann & Partner, P.O. Box 33 09 20
80069 München / DE
Application number, filing date04725184.801.04.2004
[2006/03]
WO2004JP04772
Priority number, dateJP2003009765201.04.2003         Original published format: JP 2003097652
[2006/03]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2004090541
Date:21.10.2004
Language:EN
[2004/43]
Type: A1 Application with search report 
No.:EP1617218
Date:18.01.2006
Language:EN
The application published by WIPO in one of the EPO official languages on 21.10.2004 takes the place of the publication of the European patent application.
[2006/03]
Type: B1 Patent specification 
No.:EP1617218
Date:23.02.2011
Language:EN
[2011/08]
Search report(s)International search report - published on:JP21.10.2004
(Supplementary) European search report - dispatched on:EP23.03.2007
ClassificationIPC:G01N33/68, A61K31/353
[2007/16]
CPC:
C07K14/7055 (EP,US); G01N33/53 (KR); A61K31/353 (EP,KR,US);
A61K45/00 (KR); A61P25/00 (EP); A61P25/28 (EP);
A61P35/00 (EP); A61P35/04 (EP); A61P37/08 (EP);
A61P43/00 (EP); A61P9/00 (EP); A61P9/10 (EP);
A61P9/14 (EP); G01N33/50 (KR); G01N33/6896 (EP,US);
G01N2333/7055 (EP,US) (-)
Former IPC [2006/03]G01N33/53, G01N33/50, G01N33/15, A61K45/00, A61K31/353, A61P9/00, A61P9/10, A61P25/00, A61P25/28, A61P35/00, A61P37/08
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2006/03]
Extension statesALNot yet paid
HRNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
TitleGerman:VERFAHREN ZUM SCREENING EINES ARZNEISTOFFS UNTER VERWENDUNG EINES 67 kDa GROSSEN LAMININREZEPTORS[2010/39]
English:METHOD OF SCREENING DRUG WITH THE USE OF 67 kDa LAMININ RECEPTOR[2010/39]
French:METHODE DE CRIBLAGE DE MEDICAMENT AU MOYEN DU RECEPTEUR DE LAMININE 67 kDa[2010/39]
Former [2006/03]VERFAHREN ZUM SCREENING EINES ARZNEISTOFFS UNTER VERWENDUNG EINES 67 kDa GROSSEN LAMININREZEPTORS UND DAMIT ERHALTENER ARZNEISTOFF
Former [2006/03]METHOD OF SCREENING DRUG WITH THE USE OF 67 kDa LAMININ RECEPTOR AND DRUG OBTAINED THEREBY
Former [2006/03]METHODE DE CRIBLAGE DE MEDICAMENT AU MOYEN DU RECEPTEUR DE LAMININE 67 kDa ET MEDICAMENT AINSI OBTENU
Entry into regional phase26.10.2005Translation filed 
26.10.2005National basic fee paid 
26.10.2005Search fee paid 
26.10.2005Designation fee(s) paid 
26.10.2005Examination fee paid 
Examination procedure26.10.2005Examination requested  [2006/03]
30.10.2007Despatch of a communication from the examining division (Time limit: M06)
24.04.2008Reply to a communication from the examining division
03.08.2009Despatch of a communication from the examining division (Time limit: M04)
03.12.2009Reply to a communication from the examining division
21.05.2010Cancellation of oral proceeding that was planned for 07.06.2010
07.06.2010Date of oral proceedings (cancelled)
10.06.2010Despatch of a communication from the examining division (Time limit: M04)
18.08.2010Reply to a communication from the examining division
18.10.2010Communication of intention to grant the patent
03.01.2011Fee for grant paid
03.01.2011Fee for publishing/printing paid
Opposition(s)24.11.2011No opposition filed within time limit [2012/05]
Fees paidRenewal fee
30.03.2006Renewal fee patent year 03
25.04.2007Renewal fee patent year 04
31.03.2008Renewal fee patent year 05
29.04.2009Renewal fee patent year 06
31.03.2010Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT23.02.2011
BE23.02.2011
CY23.02.2011
CZ23.02.2011
DK23.02.2011
EE23.02.2011
FI23.02.2011
HU23.02.2011
IT23.02.2011
NL23.02.2011
PL23.02.2011
RO23.02.2011
SE23.02.2011
SI23.02.2011
SK23.02.2011
TR23.02.2011
IE01.04.2011
LU01.04.2011
MC30.04.2011
BG23.05.2011
GR24.05.2011
ES03.06.2011
PT23.06.2011
[2013/45]
Former [2013/44]AT23.02.2011
BE23.02.2011
CY23.02.2011
CZ23.02.2011
DK23.02.2011
EE23.02.2011
FI23.02.2011
IT23.02.2011
NL23.02.2011
PL23.02.2011
RO23.02.2011
SE23.02.2011
SI23.02.2011
SK23.02.2011
TR23.02.2011
IE01.04.2011
LU01.04.2011
MC30.04.2011
BG23.05.2011
GR24.05.2011
ES03.06.2011
PT23.06.2011
Former [2013/25]AT23.02.2011
BE23.02.2011
CY23.02.2011
CZ23.02.2011
DK23.02.2011
EE23.02.2011
FI23.02.2011
IT23.02.2011
NL23.02.2011
PL23.02.2011
RO23.02.2011
SE23.02.2011
SI23.02.2011
SK23.02.2011
IE01.04.2011
LU01.04.2011
MC30.04.2011
BG23.05.2011
GR24.05.2011
ES03.06.2011
PT23.06.2011
Former [2012/23]AT23.02.2011
BE23.02.2011
CY23.02.2011
CZ23.02.2011
DK23.02.2011
EE23.02.2011
FI23.02.2011
IT23.02.2011
NL23.02.2011
PL23.02.2011
RO23.02.2011
SE23.02.2011
SI23.02.2011
SK23.02.2011
IE01.04.2011
MC30.04.2011
BG23.05.2011
GR24.05.2011
ES03.06.2011
PT23.06.2011
Former [2012/20]AT23.02.2011
BE23.02.2011
CY23.02.2011
CZ23.02.2011
DK23.02.2011
EE23.02.2011
FI23.02.2011
NL23.02.2011
PL23.02.2011
RO23.02.2011
SE23.02.2011
SI23.02.2011
SK23.02.2011
IE01.04.2011
MC30.04.2011
BG23.05.2011
GR24.05.2011
ES03.06.2011
PT23.06.2011
Former [2012/11]AT23.02.2011
BE23.02.2011
CY23.02.2011
CZ23.02.2011
DK23.02.2011
EE23.02.2011
FI23.02.2011
NL23.02.2011
PL23.02.2011
RO23.02.2011
SE23.02.2011
SI23.02.2011
SK23.02.2011
MC30.04.2011
BG23.05.2011
GR24.05.2011
ES03.06.2011
PT23.06.2011
Former [2012/10]AT23.02.2011
BE23.02.2011
CY23.02.2011
CZ23.02.2011
DK23.02.2011
EE23.02.2011
FI23.02.2011
NL23.02.2011
RO23.02.2011
SE23.02.2011
SI23.02.2011
SK23.02.2011
MC30.04.2011
BG23.05.2011
GR24.05.2011
ES03.06.2011
PT23.06.2011
Former [2011/51]AT23.02.2011
BE23.02.2011
CY23.02.2011
CZ23.02.2011
DK23.02.2011
EE23.02.2011
FI23.02.2011
NL23.02.2011
RO23.02.2011
SE23.02.2011
SI23.02.2011
SK23.02.2011
MC30.04.2011
BG23.05.2011
GR24.05.2011
ES03.06.2011
PT23.06.2011
PL20.07.2011
Former [2011/49]AT23.02.2011
BE23.02.2011
CY23.02.2011
CZ23.02.2011
DK23.02.2011
EE23.02.2011
FI23.02.2011
NL23.02.2011
RO23.02.2011
SE23.02.2011
SI23.02.2011
SK23.02.2011
BG23.05.2011
GR24.05.2011
ES03.06.2011
PT23.06.2011
Former [2011/47]AT23.02.2011
BE23.02.2011
CY23.02.2011
DK23.02.2011
EE23.02.2011
FI23.02.2011
NL23.02.2011
SE23.02.2011
SI23.02.2011
BG23.05.2011
GR24.05.2011
ES03.06.2011
PT23.06.2011
Former [2011/39]AT23.02.2011
BE23.02.2011
CY23.02.2011
FI23.02.2011
NL23.02.2011
SE23.02.2011
SI23.02.2011
BG23.05.2011
GR24.05.2011
ES03.06.2011
PT23.06.2011
Former [2011/37]BE23.02.2011
CY23.02.2011
FI23.02.2011
SE23.02.2011
SI23.02.2011
BG23.05.2011
GR24.05.2011
ES03.06.2011
PT23.06.2011
Former [2011/36]SE23.02.2011
GR24.05.2011
ES03.06.2011
PT23.06.2011
Documents cited:Search[X]US6410052  (MORRE DOROTHY M [US], et al) [X] 4-6,25-30* Column 1: 2.1 ; Column 14: 5.1 and claims *;
 [T]  - HOU Z ET AL, "Effects of tea polyphenols on signal transduction pathways related to cancer chemoprevention", MUTATION RESEARCH, AMSTERDAM, NL, (20041102), vol. 555, no. 1-2, ISSN 0027-5107, pages 3 - 19, XP004598056 [T] 1-30 * Item 10, first paragraph. *

DOI:   http://dx.doi.org/10.1016/j.mrfmmm.2004.06.040
 [X]  - NARUMI K ET AL, "Inhibition of experimental metastasis of human fibrosarcoma cells by anti-recombinant 37-kDa laminin binding protein antibody", JAPANESE JOURNAL OF CANCER RESEARCH, JAPANESE CANCER ASSOCIATION, TOKYO, JP, (199904), vol. 90, no. 4, ISSN 0910-5050, pages 425 - 431, XP002347726 [X] 1,2 * Discussion on pages 428-430 *
 [A]  - GEBAROWSKA DOROTA ET AL, "Synthetic peptides interacting with the 67-kd laminin receptor can reduce retinal ischemia and inhibit hypoxia-induced retinal neovascularization", AMERICAN JOURNAL OF PATHOLOGY, (200201), vol. 160, no. 1, ISSN 0002-9440, pages 307 - 313, XP002424191 [A] 1-30 * Page 308, right column, end of second paragraph; Discussion pages 311-312. *
 [A]  - TANAKA MASASHI ET AL, "Expression of the 37-kDa laminin binding protein in murine lung tumor cell correlates with tumor angiogenesis", CANCER LETTERS, (20000529), vol. 153, no. 1-2, ISSN 0304-3835, pages 161 - 168, XP002424192 [A] 1-30

DOI:   http://dx.doi.org/10.1016/S0304-3835(00)00365-7
 [PX]  - KOO ET AL, "Pharmacological effects of green tea on the gastrointestinal system", EUROPEAN JOURNAL OF PHARMACOLOGY, AMSTERDAM, NL, (20041001), vol. 500, no. 1-3, ISSN 0014-2999, pages 177 - 185, XP005480414 [PX] 1,2,4-6,12-17,25,26 * Fig. 1, page 179: paragraph bridging right and left columns *

DOI:   http://dx.doi.org/10.1016/j.ejphar.2004.07.023
International search[A]JPH06219965  (US GOVERNMENT [US]);
 [A]JPH08205885  (JOLLA CANCER RES FOUND [US]);
 [X]WO9954356  (UNIV BELFAST [GB], et al);
 [X]JP2000226329  (MEIJI MILK PROD CO LTD, et al);
 [X]JP2001114687  (MITSUI NORIN KK);
 [X]JP2002220340  (ITO EN LTD);
 [XP]  - TACHIBANA H, ET AL, "A receptor for green tea polyphenol EGCG", NAT. STRUCT. MOL. BIOL., (2004), vol. 11, no. 4, pages 380 - 381, XP002980515

DOI:   http://dx.doi.org/10.1038/nsmb743
    [ ] - PUBMED, Database accession no. 15024383
by applicant   - T. H. LANDOWSKI, BIOCHEMISTRY, (1995), vol. 34, pages 11276 - 11287
    - S. BUTO, J. CELL. BIOCHEM., (1998), vol. 69, pages 244 - 251
    - Y. SHI, CELL. MOL. LIFE SCI., (2002), vol. 59, pages 1577 - 1583
    - H. COGGIN, JR., ANTICANCER RESEARCH, (1999), vol. 19, pages 5535 - 5542
    - BREAST CANCER RESEARCH AND TREATMENT, (1998), vol. 52, pages 137 - 145
    - S. MENARD ET AL., CLINICAL CANCER RESEARCH, (1997), vol. 3, pages 227 - 231
    - G. FONTANINI ET AL., CLINICAL CANCER RESEARCH, (1996), vol. 2, pages 1777 - 1780
    - F. BASOLO; V. COICE ET AL., J. NATL. CANCER INST., (1991), vol. 83, pages 29 - 36
    - S. MENARD, BREAST CANCER RESEARCH AND TREATMENT, (1998), vol. 52, pages 137 - 145
    - K. SATOH, BRITISH JOURNAL OF CANCER, (1999), vol. 80, pages 1115 - 1122
    - M. TANAKA, CANCER LETTERS, (2000), vol. 153, pages 161 - 168
    - K. NARUMI, JPN. J. CANCER RES., (1999), vol. 90, pages 425 - 431
    - D. GEBAROWSKA, AM. J. PATHOL., (2002), vol. 160, pages 307 - 313
    - T. GLOE, J. BIOL. CHEM., (1999), vol. 274, pages 15996 - 16002
    - S. GAUCZYNSKI, EMBO J., (2001), vol. 20, pages 5863 - 5875
    - S. M. CANFIELD, J. IMMUNOL., (1999), vol. 163, pages 3430 - 3440
    - N. CLAUSSE, BIOCHEM. BIOPHYS. RES. COMMUN., (1998), vol. 251, pages 564 - 569
    - A. BRADFIELD ET AL., J. CHEM. SOC., (1947), vol. 32, page 2249
    - D. M. SMITH, INT. J. MOL. MED., (2001), vol. 7, pages 645 - 652
    - K. T. KAVANAGH, J. CELL. BIOCHEM., (2001), vol. 82, pages 387 - 398
    - N. AHMAD, ARCH. BIOCHEM. BIOPHYS., (2000), vol. 376, pages 338 - 346
    - M. SUSUKA, CANCER LETT., (1995), vol. 98, pages 27 - 31
    - M. ISEMURA, CELL BIOL. INT., (1993), vol. 17, pages 559 - 564
    - Y. SUZUKI, CANCER LETT., (2001), vol. 173, pages 15 - 20
    - S. PIANETTI, CANCER RES., (2002), vol. 62, pages 652 - 655
    - S. LAMY, CANCER RES., (2002), vol. 62, pages 381 - 385
    - A. SACHINIDIS, FASEB J., (2002), vol. 16, pages 893 - 895
    - Y. CAO, NATURE, (1999), vol. 389, page 381
    - S. HAYAKAWA, BIOCHEM. BIOPHYS. RES. COMMUN., (2001), vol. 285, pages 1102 - 1106
    - M. E. WALTNER-LAW, J. BIOL. CHEM., (2002), vol. 277, pages 34933 - 34940
    - Y. LEVITES, J. BIOL. CHEM., (2002), vol. 277, pages 30574 - 30580
    - Y. FUJIMURA, J. AGRIC. FOOD CHEM., (2002), vol. 50, pages 5729 - 5734
    - S. AHMED, FREE RADICAL BIOLOGY & MEDICINE, (2002), vol. 33, pages 1097 - 2002
    - BIOCHEMISTRY, (1995), vol. 34, pages 11276 - 11287
    - J. CELL. BIOCHEM., (1998), vol. 69, pages 244 - 251
    - CELL. MOL. LIFE SCI., (2002), vol. 59, pages 1577 - 1583
    - ANTICANCER RESEARCH, (1999), vol. 19, pages 5535 - 5542
    - CLINICAL CANCER RESEARCH, (1997), vol. 3, pages 227 - 231
    - CLINICAL CANCER RESEARCH, (1996), vol. 2, pages 1777 - 1780
    - J. NATL. CANCER INST., (1991), vol. 83, pages 29 - 36
    - BRITISH JOURNAL OF CANCER, (1999), vol. 80, pages 1115 - 1122
    - CANCER LETTERS, (2000), vol. 153, pages 161 - 168
    - JPN. J. CANCER RES., (1999), vol. 90, pages 425 - 431
    - AM. J. PATHOL., (2002), vol. 160, pages 307 - 313
    - J. BIOL. CHEM., (1999), vol. 274, pages 15996 - 16002
    - EMBO J., (2001), vol. 20, pages 5863 - 5875
    - J. IMMUNOL., (1999), vol. 163, pages 3430 - 3440
    - BIOCHEM. BIOPHYS. RES. COMMUN., (1998), vol. 251, pages 564 - 569
    - J. CHEM. SOC., (1947), vol. 32, page 2249
    - INT. J. MOL. MED., (2001), vol. 7, pages 645 - 652
    - J. CELL. BIOCHEM., (2001), vol. 82, pages 387 - 398
    - ARCH. BIOCHEM. BIOPHYS., (2000), vol. 376, pages 338 - 346
    - CANCER LETT., (1995), vol. 98, pages 27 - 31
    - CELL. BIOL. INT., (1993), vol. 17, pages 559 - 564
    - CANCER LETT., (2001), vol. 173, pages 15 - 20
    - CANCER RES., (2002), vol. 62, pages 652 - 655
    - CANCER RES., (2002), vol. 62, pages 381 - 385
    - FASEB J., (2002), vol. 16, pages 893 - 895
    - NATURE, (1999), vol. 389, page 381
    - BIOCHEM. BIOPHYS. RES. COMMUN., (2001), vol. 285, pages 1102 - 1106
    - J. BIOL. CHEM., (2002), vol. 277, pages 34933 - 34940
    - J. BIOL. CHEM., (2002), vol. 277, pages 30574 - 30580
    - J. AGRIC. FOOD CHEM., (2002), vol. 50, pages 5729 - 5734
    - FREE RADICAL BIOLOGY & MEDICINE, (2002), vol. 33, pages 1097 - 2002
    - H. YOU, PROC. NATL. ACAD. SCI. U.S.A., (1988), vol. 85, page 6394
    - YOW ET AL., PROC. NATL. ACAD. SCI. USA., (1988), vol. 85, pages 6394 - 6398
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.